Stoneridge (SRI) Tops Q2 EPS by 6c; Offers Upbeat FY23 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts SRI Hot Sheet
Price: $5.79 +0.35%
Revenue Growth %: -22.0%
Financial Fact:
Operating income: 11.78M
Today's EPS Names:
FUSE, INM, TRI, More
Revenue Growth %: -22.0%
Financial Fact:
Operating income: 11.78M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Stoneridge (NYSE: SRI) reported Q2 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $266.8 million versus the consensus estimate of $242.13 million.
GUIDANCE:
Stoneridge sees FY2023 EPS of ($0.10)-$0.10, versus the consensus of ($0.14). Stoneridge sees FY2023 revenue of $960-990 million, versus the consensus of $960 million.
For earnings history and earnings-related data on Stoneridge (SRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Tarsus Pharmaceuticals, Inc. (TARS) Misses Q3 EPS by 1293c
- Bristow Group (VTOL) Misses Q2 EPS by 24c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
